Ligand Pharmaceuticals
LGND
#2784
Rank
โ‚ฌ5.36 B
Marketcap
269,12ย โ‚ฌ
Share price
0.07%
Change (1 day)
74.16%
Change (1 year)

Revenue for Ligand Pharmaceuticals (LGND)

Revenue in 2026 (TTM): โ‚ฌ0.24 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.25 Billion. In 2025 the company made a revenue of โ‚ฌ0.22 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ0.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ligand Pharmaceuticals from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.24 B9.4%
2025 โ‚ฌ0.22 B42.09%
2024 โ‚ฌ0.16 B35.21%
2023 โ‚ฌ0.11 B-26.31%
2022 โ‚ฌ0.16 B-34.13%
2021 โ‚ฌ0.24 B61.46%
2020 โ‚ฌ0.15 B41.15%
2019 โ‚ฌ0.10 B-51.15%
2018 โ‚ฌ0.21 B86.91%
2017 โ‚ฌ0.11 B13.51%
2016 โ‚ฌ0.10 B57.52%
2015 โ‚ฌ65.77 M23.94%
2014 โ‚ฌ53.06 M49.64%
2013 โ‚ฌ35.46 M49.44%
2012 โ‚ฌ23.72 M2.6%
2011 โ‚ฌ23.12 M30.7%
2010 โ‚ฌ17.69 M-34.89%
2009 โ‚ฌ27.18 M39.11%
2008 โ‚ฌ19.53 M121.26%
2007 โ‚ฌ8.83 M-84.42%
2006 โ‚ฌ56.69 M-59.01%
2005 โ‚ฌ0.13 B18.33%
2004 โ‚ฌ0.11 B4.27%
2003 โ‚ฌ0.11 B21.26%
2002 โ‚ฌ92.44 M6.95%
2001 โ‚ฌ86.44 M66.95%
2000 โ‚ฌ51.77 M27.5%
1999 โ‚ฌ40.61 M172.27%
1998 โ‚ฌ14.91 M-65.76%
1997 โ‚ฌ43.56 M39.73%
1996 โ‚ฌ31.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ86.99 B 33,605.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ56.58 B 21,822.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ70.76 B 27,319.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ33.83 B 13,011.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ10.18 B 3,847.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ59.13 B 22,812.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ43.69 B 16,829.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ39.38 B 15,161.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
โ‚ฌ22.85 M-91.14%๐Ÿ‡บ๐Ÿ‡ธ USA